or
forgot password

    • cancer clinical trials in berkeley, CA

    • Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    S0820, Adenoma and Second Primary Prevention Trial
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Colorectal Neoplasms
    A Study of the Safety, Tolerability, and Efficacy of MK-8353 in Participants With Advanced Solid Tumors (MK-8353-001 AM4)
    Call for Information (Investigational Site 0015)
    Berkeley, California 94704
    Tumor, Solid
    S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Arthralgia, Breast Cancer, Pain
    Dietary Protein Sources and Atherogenic Dyslipidemia
    Cholesterol Research Center, Children's Hospital Research Institute
    Berkeley, California 94705
    Cardiovascular Disease, Dyslipidemia, Insulin Resistance, Inflammation
    Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma, Peripheral T-cell Lymphoma, Recurrent Adult Non-Hodgkin Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma
    Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma
    East Bay AIDS Ctr
    Berkeley, California 94705
    Sarcoma, Kaposi, HIV Infections
    The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients
    East Bay AIDS Ctr
    Berkeley, California 94705
    HIV Infections, Condyloma Acuminata
    Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Anemia, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Anal Cancer
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Melanoma (Skin)
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Breast Cancer
    Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Metastatic Cancer
    Bladder Cancer Case Control Study of Arsenic in Water
    Allan Smith Research Office
    Berkeley, California 94720
    Bladder Cancer
    Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Breast Cancer
    Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Gemcitabine With or Without Erlotinib in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Pancreatic Cancer
    DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Meningeal Neoplasms
    S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)
    Research Center
    Berkeley, California 94704
    Carcinoma, Non-Small-Cell Lung, Lung Neoplasms
    Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin
    Gastroenterology Associates of East Bay Medical Group
    Berkeley, California
    Hepatitis C, Hepatitis C, Chronic
    Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
    Gastroenterology Associates of East Bay Medical Group
    Berkeley, California
    Hepatitis C, Hepatitis C, Chronic
    OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Pancreatic Cancer
    Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Peripheral Nervous System Diseases, Chemotherapy-Induced Peripheral Neuropathy
    Decitabine Versus Supportive Care in Adults With Advanced-stage MDS
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Myelodysplastic Syndrome
    D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Fatigue, Neoplasms
    PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Multiple Myeloma
    S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Leukemia
    Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Colorectal Carcinoma
    VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
    Alta Bates Medical Center
    Berkeley, California 94704
    Mantle Cell Lymphoma
    Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes
    Alta Bates Cancer Center
    Berkeley, California 94704
    Myelodysplastic Syndromes
    Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Multiple Myeloma
    Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Carcinoma, Non-Small-Cell Lung
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Pancreatic Cancer
    Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Breast Cancer, Metastases
    Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma
    Alta Bates Cancer Center
    Berkeley, California 94704
    Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
    Alta Bates Comp. Cancer Ctr
    Berkeley, California 94704
    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
    S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Esophageal Cancer
    Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)
    University of Miami

    Trial Locations
    University of Miami
    Alta Bates Comprehsenive Cancer Center
    Leukemia, Myeloid, Chronic Phase
    Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma
    Alta Bates Cancer Center
    Berkeley, California 94704
    Non-Hodgkins Lymphoma
    A Phase III Trial For Patients With Metastatic Breast Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician.
    Berkeley, California
    Breast Cancer, Breast Neoplasms, Cancer of the Breast
    S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Sarcoma
    Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Tumor Lysis Syndrome, Cancer, Hyperuricemia
    Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Thalassemia, Sickle Cell Disease, Diamond Blackfan Anemia, Myelofibrosis
    Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Breast Neoplasm
    Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.
    Alta Bates Medical Center - Comprehensive Cancer Center
    Berkeley, California 94704
    Small Cell Lung Cancer
    A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Oral Mucositis, Stomatitis
    Case-Control Study of Pesticides and Childhood Leukemia
    University of California, Berkeley
    Berkeley, California 94720-0001
    Childhood Leukemia
    A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma
    AOI Pharmaceuticals Investigative Site
    Berkeley, California 94704
    Glioma, Astrocytoma, Oligodendroglioma, Oligoastrocytoma
    Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
    AOI Pharmaceuticals Investigative Site
    Berkeley, California 94704
    Colon Cancer